Search Results 81-90 of 63016 for covid-19

  1. Hospital Experiences to Advance Goals and Outcomes Network (HEXAGON) - COVID-19 Outcomes Research on Acute and Long-Term Health Events (CORAL) Initiative

    The Hospital Experiences to Advance Goals and Outcomes Network (HEXAGON) studies symptoms, comorbidities & outcomes of patients hospitalized for COVID-19 at ...

  2. COVID-19 - 2023 Archives - Mayo Clinic News Network

    Respiratory viruses like COVID-19 and influenza surge in the colder months. And it's not just because people are spending more time indoors.

  3. COVID-19 Biobank - Clinical Trials

    The purpose of this research repository is to prospectively collect research biospecimens and corresponding clinical and patient provided data from COVID-19 ...

  4. COVID-19: Hope for the future as world passes deadly milestone - Mayo Clinic News Network

    A grim tally was revealed this week, as the global death toll from COVID-19 surpassed 6 million, according to data from Johns Hopkins University.

  5. Bebtelovimab (intravenous route) - Side effects & uses - Mayo Clinic

    Bebtelovimab injection is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in patients with positive results of direct SARS-CoV-2 testing, who ...

  6. Losartan for Outpatients on COVID-19 - Clinical Trials

    About this study. This is a multicenter randomized controlled trial comparing losartan vs placebo for outpatients with COVID. Every patient that is tested ...

  7. Mayo Clinic Q&A podcast: On the verge of another COVID-19 surge

    As spring break travelers return home and the highly transmissible U.K. COVID-19 variant is discovered in all 50 U.S. states, the country is on the verge of ...

  8. Mayo Clinic Q&A podcast: COVID-19 modeling shows 100,000 people in the U.S. could die over the next 3 months

    U.S. hospitalizations for patients with COVID-19 have risen almost 500% over the past two months, according to news reports. Also, the number of ICU beds in ...

  9. Nirmatrelvir and ritonavir (oral route) - Side effects & dosage - Mayo Clinic

    Nirmatrelvir and ritonavir combination is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk ...

  10. Evaluation of the Effects of Caffeine, Via the ACE2 Receptor, on Clinical Severity of COVID-19 Disease

    The purpose of this study is to assess levels of caffeine intake among patients who tested positive for COVID-19 infection and compare that to disease severity.